MarginsXMarginsX
Home › Markets › VNOV

VitaNova Life Sciences Corp (VNOV)

VNOV is quoted over the counter, not listed on an exchange. VitaNova Life Sciences Corp files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 13, 2026
$2.82
+22.4% on the day
1-year return
-41.6%
Market cap
$23.5M
Nano cap. From the Nov 13, 2026 close × 8.3M shares (10-Q cover page, Sep 14, 2026)
P/E and P/S
Net loss over the period · 7.2×
On trailing twelve months to July 31, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerVNOV, quoted over the counter
SEC CIK0001699709
OTC Markets tierOTCID (price source, 2026-11-13)
SEC industry codeWholesale-Apparel, Piece Goods & Notions
Business addressNew York, NY
Incorporated inNV

Warning signs

Cash runway
Cash-flow positive
$1.6M cash at July 31, 2026
Share count, 1 year
0.0%
2025-09-12 to 2026-09-14 · +326.0% over 3 years
Going-concern doubt
No
10-Q filed September 14, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-09-14
Cash and burn$1.6M cash; operating cash flow $139K a quarter.Report 2026-07-31
Shares outstanding8,337,454 (2026-09-14); 25,012,270 a year earlier; 5,871,250 three years earlier. 1y figure adjusted for split (1-for-3 overall); 3y figure adjusted for split (1-for-3 overall).Cover page 2026-09-14
Reverse splits, 3 years1; latest 1-for-3 on 2026-01-27Source 2026-01-27
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorSimon & Edward, LLP, Rowland Heights, California, United StatesPCAOB Form AP 2026-08-06
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q1 2027
2026-07-31
$322K-$123K$7K$1.6MNo debt tags$3.2M10-Q 2026-09-14
Q4 2026
2026-04-30
$1.8M$18K$428K$1.6MNo debt tags$3.0M10-K 2026-07-29
Q3 2026
2026-01-31
$710K-$44K-$90K$1.2MNo debt tags$3.2M10-Q 2026-03-16
Q2 2026
2025-10-31
$427K$36K$213K$1.3MNo debt tags$2.8M10-Q 2025-12-15
Q1 2026
2025-07-31
$104K-$46K$264K$1.0MNo debt tags$2.7M10-Q 2026-09-14
Q4 2025
2025-04-30
$2.0M$800K$479K$783KNo debt tags$2.7M10-K 2026-07-29
Q3 2025
2025-01-31
$308K$73K$209K$405KNo debt tags$1.3M10-Q 2026-03-16
Q2 2025
2024-10-31
$292K$33K$9K$223KNo debt tags$971K10-Q 2025-12-15

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentPOS AM2023-05-24
Latest annual report10-K2026-07-29
Latest quarterly / interim10-Q2026-09-14
Latest current report8-K2026-03-18

Source: SEC EDGAR submissions feed, 97 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier